Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Treasury Shares (2016 - 2025)

Historic Treasury Shares for BioCorRx (BICX) over the last 13 years, with Q3 2025 value amounting to $1.6 million.

  • BioCorRx's Treasury Shares fell 882.4% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 882.4%. This contributed to the annual value of $1.4 million for FY2024, which is 1809.04% down from last year.
  • As of Q3 2025, BioCorRx's Treasury Shares stood at $1.6 million, which was down 882.4% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Treasury Shares registered a high of $1.9 million during Q1 2025, and its lowest value of $815351.0 during Q3 2021.
  • In the last 5 years, BioCorRx's Treasury Shares had a median value of $908968.5 in 2023 and averaged $1.2 million.
  • As far as peak fluctuations go, BioCorRx's Treasury Shares soared by 10202.96% in 2023, and later plummeted by 1809.04% in 2024.
  • Over the past 5 years, BioCorRx's Treasury Shares (Quarter) stood at $815351.0 in 2021, then increased by 7.2% to $874058.0 in 2022, then skyrocketed by 102.03% to $1.8 million in 2023, then fell by 18.09% to $1.4 million in 2024, then increased by 11.31% to $1.6 million in 2025.
  • Its Treasury Shares stands at $1.6 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.9 million for Q1 2025.